Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Proto Labs (PRLB) EBT (2016 - 2025)

Proto Labs' EBT history spans 14 years, with the latest figure at $8.2 million for Q4 2025.

  • For Q4 2025, EBT rose 2990.78% year-over-year to $8.2 million; the TTM value through Dec 2025 reached $31.1 million, up 25.9%, while the annual FY2025 figure was $31.1 million, 25.9% up from the prior year.
  • EBT for Q4 2025 was $8.2 million at Proto Labs, down from $10.3 million in the prior quarter.
  • Across five years, EBT topped out at $16.2 million in Q2 2021 and bottomed at -$116.7 million in Q4 2022.
  • The 5-year median for EBT is $7.2 million (2021), against an average of $1.3 million.
  • The largest annual shift saw EBT crashed 1002.44% in 2022 before it surged 2990.78% in 2025.
  • A 5-year view of EBT shows it stood at $12.9 million in 2021, then plummeted by 1002.44% to -$116.7 million in 2022, then skyrocketed by 108.52% to $9.9 million in 2023, then crashed by 102.84% to -$282000.0 in 2024, then soared by 2990.78% to $8.2 million in 2025.
  • Per Business Quant, the three most recent readings for PRLB's EBT are $8.2 million (Q4 2025), $10.3 million (Q3 2025), and $6.7 million (Q2 2025).